Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond S Norton

Showing results (1-10 of 251) with videos related to

Pageof 26
Sort By:
Expert Opinion on Drug Discovery|April 12, 2017
Enhancing the therapeutic potential of peptide toxinsRaymond S Norton
Toxicon : Official Journal of the International Society on Toxinology|March 17, 2009
Structures of sea anemone toxinsRaymond S Norton
Protein and Peptide Letters|November 2, 2018
Anti-Infective Peptides to Enhance the Host Innate Response: Design, Development and DeliveryRaymond S Norton
Molecules (Basel, Switzerland)|April 30, 2010
Mu-conotoxins as leads in the development of new analgesicsRaymond S Norton
Journal of Biomolecular NMR|November 13, 2020
Correction to: NMR in pharmaceutical discovery and developmentRaymond S Norton, Wolfgang Jahnke
Journal of Biomolecular NMR|September 5, 2020
NMR in pharmaceutical discovery and developmentRaymond S Norton, Wolfgang Jahnke
Future Medicinal Chemistry|November 19, 2014
Computational approaches for designing potent and selective analogs of peptide toxins as novel therapeuticsSerdar Kuyucak, Raymond S Norton
Toxicon: X|February 24, 2022
<i>Toxicon</i> and <i>Toxicon: X</i> - 2022 and beyondRaymond S Norton, Denise V Tambourgi
Marine Drugs|December 19, 2014
Conotoxin gene superfamiliesSamuel D Robinson, Raymond S Norton
Current Opinion in Chemical Biology|April 17, 2017
Peptide blockers of K<sub>v</sub>1.3 channels in T cells as therapeutics for autoimmune diseaseK George Chandy, Raymond S Norton
Pageof 26

Showing results (1-10 of 251) with videos related to

Sort By:
Pageof 26
Expert Opinion on Drug Discovery|April 12, 2017
Enhancing the therapeutic potential of peptide toxinsRaymond S Norton
Toxicon : Official Journal of the International Society on Toxinology|March 17, 2009
Structures of sea anemone toxinsRaymond S Norton
Protein and Peptide Letters|November 2, 2018
Anti-Infective Peptides to Enhance the Host Innate Response: Design, Development and DeliveryRaymond S Norton
Molecules (Basel, Switzerland)|April 30, 2010
Mu-conotoxins as leads in the development of new analgesicsRaymond S Norton
Journal of Biomolecular NMR|November 13, 2020
Correction to: NMR in pharmaceutical discovery and developmentRaymond S Norton, Wolfgang Jahnke
Journal of Biomolecular NMR|September 5, 2020
NMR in pharmaceutical discovery and developmentRaymond S Norton, Wolfgang Jahnke
Future Medicinal Chemistry|November 19, 2014
Computational approaches for designing potent and selective analogs of peptide toxins as novel therapeuticsSerdar Kuyucak, Raymond S Norton
Toxicon: X|February 24, 2022
<i>Toxicon</i> and <i>Toxicon: X</i> - 2022 and beyondRaymond S Norton, Denise V Tambourgi
Marine Drugs|December 19, 2014
Conotoxin gene superfamiliesSamuel D Robinson, Raymond S Norton
Current Opinion in Chemical Biology|April 17, 2017
Peptide blockers of K<sub>v</sub>1.3 channels in T cells as therapeutics for autoimmune diseaseK George Chandy, Raymond S Norton
Pageof 26